Takeda Pharmaceutical (TAK) Insider Trading & Ownership $12.94 -0.11 (-0.80%) As of 01/17/2025 03:59 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Takeda Pharmaceutical (NYSE:TAK) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.04%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$30.00 M Get TAK Insider Trade Alerts Want to know when executives and insiders are buying or selling Takeda Pharmaceutical stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address TAK Insider Buying and Selling by Quarter Takeda Pharmaceutical Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/24/2024Pharmaceutical Co Ltd TakedaMajor ShareholderSell3,703,703$8.10$29,999,994.30 (Data available from 1/1/2013 forward) TAK Insider Trading Activity - Frequently Asked Questions Who is on Takeda Pharmaceutical's Insider Roster? The list of insiders at Takeda Pharmaceutical includes Pharmaceutical Co Ltd Takeda. Learn more on insiders at TAK. What percentage of Takeda Pharmaceutical stock is owned by insiders? 0.04% of Takeda Pharmaceutical stock is owned by insiders. Learn more on TAK's insider holdings. Which Takeda Pharmaceutical insiders have been selling company stock? The following insider sold TAK shares in the last 24 months: Pharmaceutical Co Ltd Takeda ($29,999,994.30). How much insider selling is happening at Takeda Pharmaceutical? Insiders have sold a total of 3,703,703 Takeda Pharmaceutical shares in the last 24 months for a total of $29,999,994.30 sold. Takeda Pharmaceutical Key ExecutivesMr. Christophe Weber (Age 58)President, CEO & Representative Director Compensation: $3.74MDr. Andrew S. Plump (Age 59)President of Research & Development and Representative Director Compensation: $2.67MDr. Seigo IzumoChair of Management BoardMr. Milano Furuta (Age 46)Chief Financial Officer Mr. Haruhiko Hirate (Age 67)Member of Management Board Mr. Salvatore Alesci M.D. (Age 49)Ph.D., Member of Management Board and Head of R&D Global Science & Biomedical Policy Norimasa TakedaChief Accounting Officer & Corporate ControllerMr. Iwaaki TaniguchiSenior Vice President of Corporate Finance & Controlling DepartmentMr. Gabriele Ricci (Age 46)Chief Data & Technology Officer Mr. Christopher David O'ReillyGlobal Head of Investor Relations & Global Finance More Insider Trading Tools from MarketBeat Related Companies Sanofi Insider Ownership GSK Insider Ownership argenx Insider Ownership BioNTech Insider Ownership Teva Pharmaceutical Industries Insider Ownership BeiGene Insider Ownership Genmab A/S Insider Ownership Viatris Insider Ownership Intra-Cellular Therapies Insider Ownership Summit Therapeutics Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NYSE:TAK) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Takeda Pharmaceutical Company Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Takeda Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
